2025 Annual Meeting | S12 - Practice, Policy, and Ethics
Program Materials Program Evaluations
| 11:15 AM - 11:27 AM PDT | Abstract |
001 - Gender, Racial, and Ethnic Representation Among US Neurology Faculty From 1972 to 2021
Chia-Chen Tsai |
| 11:27 AM - 11:39 AM PDT | Abstract |
002 - Interim Results of the US Fenfluramine Oral Solution Cardiovascular Safety Registry Study
Almasa Bass |
| 11:39 AM - 11:51 AM PDT | Abstract |
003 - Optimizing Diagnostic Workup and Clinical Treatment of the Neuropathic Subtype of Postural Orthostatic Tachycardia Syndrome (POTS)
Ryan Rilinger |
| 11:51 AM - 12:03 PM PDT | Abstract |
004 - Identifying Trends to Reduce Stroke Readmissions
Brian E. Herman, DO |
| 12:03 PM - 12:15 PM PDT | Abstract |
005 - The Impact of Language Barriers on the Care of Dizzy Patients in the Emergency Department at a Large Academic Center
Jin Kyung Kim, MD |
| Fariha Jamal, MD | Dr. Jamal has nothing to disclose. |
| Ryan Rilinger | Mr. Rilinger has nothing to disclose. |
| Christopher J. Cantrell | Mr. Cantrell has nothing to disclose. |
| Samantha J. Tidd, MD | Mrs. Tidd has nothing to disclose. |
| Robert G. Wilson, DO | Dr. Wilson has nothing to disclose. |
| Brian E. Herman, DO | Dr. Herman has nothing to disclose. |
| Yunxia Wang, MD, FAAN | Dr. Wang has nothing to disclose. |
| Chaeli A. Stenuf, RN | Rev. Stenuf has nothing to disclose. |
| Chia-Chen Tsai | Ms. Tsai has received research support from Foundation of the Consortium of Multiple Sclerosis Centers. Ms. Tsai has received research support from UBC Multiple Sclerosis Connect Program. |
| Chen Hu | Chen Hu has nothing to disclose. |
| Jeffrey Ding, MD | Dr. Ding has nothing to disclose. |
| Esther Bui, MD | Dr. Bui has received publishing royalties from a publication relating to health care. |
| Aleksandra Pikula, MD | The institution of Dr. Pikula has received research support from CIHR. |
| Thalia S. Field, MD | Dr. Field has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Field has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Field has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Field has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Field has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Canadian Medical Protective Association, plaintiff. The institution of Dr. Field has received research support from Heart and Stroke Foundation, Brain Canada and CIHR. Dr. Field has a non-compensated relationship as a Editorial board with Stroke that is relevant to AAN interests or activities. Dr. Field has a non-compensated relationship as a Editorial board with CJNS that is relevant to AAN interests or activities. Dr. Field has a non-compensated relationship as a Editorial board with JNNP that is relevant to AAN interests or activities. Dr. Field has a non-compensated relationship as a Board member with DESTINE Health that is relevant to AAN interests or activities. Dr. Field has a non-compensated relationship as a Board Member with Vancouver General Hospital Foundation that is relevant to AAN interests or activities. |
| Sabeen Tiwana, DMD | Dr. Tiwana has nothing to disclose. |
| Javed Siddiqi, MD, PhD | Dr. Siddiqi has nothing to disclose. |
| Faisal Khosa, MD | Dr. Khosa has nothing to disclose. |
| Almasa Bass | Almasa Bass has received personal compensation for serving as an employee of UCB. Almasa Bass has stock in UCB. |
| Diego Morita, MD | Dr. Morita has received personal compensation for serving as an employee of UCB Biosciences, Inc. Dr. Morita has stock in UCB, Inc. |
| Julie A. Shepherd-Smith, PharmD | Mrs. Shepherd-Smith has received personal compensation for serving as an employee of UCB Pharma S.A. Mrs. Shepherd-Smith has stock in UCB Pharma S.A. |
| Rebecca Zhang-Roper, MD, PhD | Dr. Zhang-Roper has received personal compensation for serving as an employee of UCB. |
| Aleksey Gitelson, PharmD | Dr. Gitelson has received personal compensation for serving as an employee of UCB Biosciences Inc.. An immediate family member of Dr. Gitelson has received personal compensation for serving as an employee of Biogen Inc. Dr. Gitelson has stock in UCB Biosciences Inc.. An immediate family member of Dr. Gitelson has stock in Biogen Inc. |
| Evi Tselenti | Miss Tselenti has nothing to disclose. |
| Amelie Lothe, PhD | Dr. Lothe has received personal compensation for serving as an employee of UCB. Dr. Lothe has stock in UCB. |
| Jenna S. Roberts, PhD | Dr. Roberts has received personal compensation for serving as an employee of UCB Pharma. Dr. Roberts has stock in UCB Pharma. |
| Namita Nayak | No disclosure on file |
| Rachelle Dugue, MD, PhD | Dr. Dugue has nothing to disclose. |
| Richard Baron, MD | Dr. Baron has nothing to disclose. |
| Jin Kyung Kim, MD | Dr. Kim has nothing to disclose. |
| Diana M. Barratt, MD, MPH, FAAN | Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Legally Pink, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Vlantis Law, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Traub Lieberman. |